课题基金 / 基金详情

Towards improved respiratory outcomes in preterm infants through rapid and effective aerosalisation of medication to the lung

Towards improved respiratory outcomes in preterm infants through rapid and effective aerosalisation of medication to the lung
通过快速有效地将药物气雾化至肺部,改善早产儿的呼吸结果
批准号:
nhmrc : GNT1123030
负责人:
Dr Anushi Rajapaksa
金额:
$31.88万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Early Career Fellowships
财政年份:
2017
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2017-01-01 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
早产儿患上日益常见的呼吸道疾病的风险最大。通过气雾剂给药可能是最有效的治疗方法。对于需要呼吸支持的早产儿,吸入药物可以改善护理。对于高度传染性的呼吸道疾病,如RSV,由于没有疫苗可用,我们需要在生命的早期保护婴儿。我将使用一个已建立的羔羊模型来测试快速药物输送到肺部。
英文摘要
Babies born premature are greatest at risk from increasingly common respiratory illnesses. It is possible that delivering a medication by aerosol will be the most effective method of treatment. For premature babies that need breathing support, inhaled medication could improve care. For highly infectious respiratory illnesses such as RSV, with no vaccines available, we need to protect babies very early in life. I will use an established lamb model to test fast medication delivery to the lungs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金